← Back to Ennoble
The Reality of Failure
FDA Breakthrough Designation: What It Really Means for Neurostimulation Devices
An insider's perspective on navigating the FDA Breakthrough Device Designation pathway — candid lessons from CBOT-P's chronic pain management journey.
Mar 10, 20248 min readVamsi Reddy
Read the full piece
This piece is published in full on the Ennoble channel — Vamsi Reddy's platform for long-form perspectives on MedTech, regulatory strategy and biomedical innovation.
Watch on YouTube →Continue reading